Simpson Thacher represented J.P. Morgan Securities LLC and BofA Securities, Inc., among others, as underwriters in connection with the offering by a certain selling stockholder of 15,000,000 shares of common stock of R1 RCM Inc. (“R1 RCM”). The secondary offering, which was effected pursuant to a block trade, raised gross proceeds for the selling stockholder of approximately $306.4 million.
R1 RCM (NASDAQ: RCM) is a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. R1 RCM’s services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician and staff satisfaction for its customers.
The Simpson Thacher team included Joe Kaufman, Ryan Bekkerus, Anna Jarman and Jimmy Leyden (Capital Markets); Michael Mann (Tax); Jamin Koslowe (Executive Compensation and Employee Benefits); Vanessa Burrows and Tera Rule (Healthcare); Alysha Sekhon (Intellectual Property); Noreen Lavan (Environmental); and Jennie Getsin (FINRA & Blue Sky).